Details for New Drug Application (NDA): 062055
✉ Email this page to a colleague
The generic ingredient in ERYTHROMYCIN ETHYLSUCCINATE is erythromycin ethylsuccinate; sulfisoxazole acetyl. There are one hundred and three drug master file entries for this compound. Additional details are available on the erythromycin ethylsuccinate; sulfisoxazole acetyl profile page.
Summary for 062055
Tradename: | ERYTHROMYCIN ETHYLSUCCINATE |
Applicant: | Ani Pharms |
Ingredient: | erythromycin ethylsuccinate |
Patents: | 0 |
Pharmacology for NDA: 062055
Physiological Effect | Decreased Sebaceous Gland Activity |
Medical Subject Heading (MeSH) Categories for 062055
Suppliers and Packaging for NDA: 062055
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ERYTHROMYCIN ETHYLSUCCINATE | erythromycin ethylsuccinate | GRANULE;ORAL | 062055 | ANDA | ANI Pharmaceuticals, Inc. | 62559-440 | 62559-440-02 | 200 mL in 1 BOTTLE (62559-440-02) |
ERYTHROMYCIN ETHYLSUCCINATE | erythromycin ethylsuccinate | GRANULE;ORAL | 062055 | ANDA | ANI Pharmaceuticals, Inc. | 62559-630 | 62559-630-01 | 100 mL in 1 BOTTLE (62559-630-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | GRANULE;ORAL | Strength | EQ 200MG BASE/5ML | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | GRANULE;ORAL | Strength | EQ 400MG BASE/5ML | ||||
Approval Date: | Nov 2, 2018 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | GRANULE;ORAL | Strength | EQ 200MG BASE/5ML | ||||
Approval Date: | Nov 2, 2018 | TE: | AB | RLD: | No |
Complete Access Available with Subscription